Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.

<h4>Background</h4>Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yong Liu, An-Qiang Zhang, Lin Cao, Hong-Tao Xia, Jun-Jie Ma
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8d2dbe213b024f1780d8adbce8cb1ec6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d2dbe213b024f1780d8adbce8cb1ec6
record_format dspace
spelling oai:doaj.org-article:8d2dbe213b024f1780d8adbce8cb1ec62021-11-18T08:45:19ZTaurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.1932-620310.1371/journal.pone.0079417https://doaj.org/article/8d2dbe213b024f1780d8adbce8cb1ec62013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24278133/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs.<h4>Methods</h4>We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity.<h4>Results</h4>Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28).<h4>Conclusions</h4>The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.Yong LiuAn-Qiang ZhangLin CaoHong-Tao XiaJun-Jie MaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79417 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yong Liu
An-Qiang Zhang
Lin Cao
Hong-Tao Xia
Jun-Jie Ma
Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
description <h4>Background</h4>Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs.<h4>Methods</h4>We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity.<h4>Results</h4>Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28).<h4>Conclusions</h4>The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.
format article
author Yong Liu
An-Qiang Zhang
Lin Cao
Hong-Tao Xia
Jun-Jie Ma
author_facet Yong Liu
An-Qiang Zhang
Lin Cao
Hong-Tao Xia
Jun-Jie Ma
author_sort Yong Liu
title Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
title_short Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
title_full Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
title_fullStr Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
title_full_unstemmed Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
title_sort taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/8d2dbe213b024f1780d8adbce8cb1ec6
work_keys_str_mv AT yongliu taurolidinelocksolutionsforthepreventionofcatheterrelatedbloodstreaminfectionsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT anqiangzhang taurolidinelocksolutionsforthepreventionofcatheterrelatedbloodstreaminfectionsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT lincao taurolidinelocksolutionsforthepreventionofcatheterrelatedbloodstreaminfectionsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hongtaoxia taurolidinelocksolutionsforthepreventionofcatheterrelatedbloodstreaminfectionsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT junjiema taurolidinelocksolutionsforthepreventionofcatheterrelatedbloodstreaminfectionsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
_version_ 1718421334179971072